First-time users were defined as individuals who did not have GLP-1 RAs listed on their health records for at least 365 days and who only initiated the medications as a second-line treatment to metformin
Its not about knowing what to eat and not eat, or how to exerciseI have all the knowledge, says the self-described health nut who ultimately turned to semaglutide to get back to her pre-menopausal weight
Vendors should clearly state that products are intended solely for laboratory research use, not human consumption or veterinary applications
But as popularity has increased, more questions are being asked about the side effects these medications are causing
Competition in the GLP-1 sector is never about elimination, but about leveraging respective strengths to advance the development of metabolic disease treatments
For the right patient, they produce 1520% weight loss alongside meaningful improvements in blood sugar, blood pressure, cholesterol, and even cardiovascular outcomes